Skip to content

Reward and Punishment Sensitivity in Bipolar Disorders

Reward and Punishment Sensitivity in Bipolar Disorders

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04237610
Acronym
Recodec-BP
Enrollment
90
Registered
2020-01-23
Start date
2020-02-24
Completion date
2022-02-23
Last updated
2020-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder

Keywords

reinforcement learning

Brief summary

Bipolar disorder (BD) represents a chronic mood disorder and one of the leading causes of disability worldwide. Complexity of its clinical presentations leads to delayed diagnosis and difficult management in routine clinical settings. Whereas distinguishing BD-I and BD-II main subtypes has a significant relevance for treatment strategy and for outcome, there are currently no clinical determinants of the BD subtype which could be used as early diagnostic predictors. * While neurobiological specificity of each BD subtype is still controversial, available evidence suggest different dopaminergic abnormalities in each subtype. Dopaminergic function is involved in decision making and reward processing which may represent useful BD subtype markers. * This study aims at assessing decision making during appetitive and punitive reinforcement learning in patients with BD I and BD II subtypes compared to healthy controls

Interventions

Probabilistic learning task

Sponsors

University Hospital, Grenoble
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* bipolar disorder (BD) type I or II, according to DSM (Diagnostic and Statistical Manual)-5 criteria * Montgomery and Asberg Depression Rating Scale (MADRS) score \< 15 * Young Mania Rating Scale (YMRS) score \< 12

Exclusion criteria

* other main diagnosis than bipolar disorder * other medical condition leading to cognitive deterioration

Design outcomes

Primary

MeasureTime frameDescription
Response performance in reward and loss trialsone day visitpercentage of correct responses in the probabilistic learning task

Countries

France

Contacts

Primary ContactMircea POLOSAN, MD, PhD
mpolosan@chu-grenoble.fr0033476765414
Backup ContactArnaud POUCHON, MD
apouchon@chu-grenoble.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026